| Name | Title | Contact Details |
|---|
Continental Industries Group is a New York, NY-based company in the Business Services sector.
Craciun Research Group Inc is a Anchorage, AK-based company in the Business Services sector.
Invacare U.S. is a prominent manufacturer and distributor of non-acute healthcare products, with a history dating back to 1885. Originally founded as Fay Manufacturing Company in Elyria, Ohio, the company transitioned from producing tricycles to becoming a leader in mobility devices for individuals with disabilities. Invacare focuses on providing customer-centric solutions in home and long-term care medical products. The company offers a diverse range of products to support individuals requiring home healthcare and rehabilitative care. Their offerings include mobility aids such as power and manual wheelchairs, seating and positioning products, walking aids like crutches and walkers, home care beds, respiratory products, and safety equipment. Invacares products cater to individuals with disabilities, healthcare providers, and organizations involved in home and long-term care. In November 2024, Invacares North American business was acquired by MIGA Holdings LLC, which aims to enhance operations and growth in the region. The company has a strong history of innovation, being the first to introduce a motorized wheelchair with computerized controls in 1982, and continues to advance wheelchair design and technology.
Centre canadien de leadership en evaluation is a Ottawa, ON-based company in the Business Services sector.
Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. We have a proven strategy of advancing clinically validated mechanisms previously held back by limitations we overcome with our proprietary Glyph technology platform. All the therapeutic candidates in our pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely designed to enable oral bioavailability, bypass first-pass metabolism and reduce hepatotoxicity and other side effects. We are led by an experienced team that was involved in inventing and developing KarXT and other neuropsychiatric medicines, and are guided by an extensive network of renowned scientists, clinicians and key opinion leaders. For more information, please visit www.seaporttx.com or connect with us on X (formerly Twitter) @SeaportTx